1 Ho, W. J., Jaffee, E. M. & Zheng, L. The tumour microenvironment in pancreatic cancer - clinical challenges and opportunities. Nature reviews. Clinical oncology, doi:10.1038/s41571-020-0363-5 (2020).
2 McGranahan, N. & Swanton, C. Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future. Cell 168, 613-628, doi:10.1016/j.cell.2017.01.018 (2017).
3 Augsten, M. Cancer-associated fibroblasts as another polarized cell type of the tumor microenvironment. Frontiers in oncology 4, 62, doi:10.3389/fonc.2014.00062 (2014).
4 Kalluri, R. The biology and function of fibroblasts in cancer. Nat Rev Cancer 16, 582-598, doi:10.1038/nrc.2016.73 (2016).
5 Hanahan, D. & Coussens, L. M. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 21, 309-322, doi:10.1016/j.ccr.2012.02.022 (2012).
6 Sahai, E. et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer 20, 174-186, doi:10.1038/s41568-019-0238-1 (2020).
7 Tian, C. et al. Proteomic analyses of ECM during pancreatic ductal adenocarcinoma progression reveal different contributions by tumor and stromal cells. Proceedings of the National Academy of Sciences of the United States of America 116, 19609-19618, doi:10.1073/pnas.1908626116 (2019).
8 Laklai, H. et al. Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression. Nat Med 22, 497-505, doi:10.1038/nm.4082 (2016).
9 Olivares, O. et al. Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions. Nature communications 8, 16031, doi:10.1038/ncomms16031 (2017).
10 Mohammadi, H. & Sahai, E. Mechanisms and impact of altered tumour mechanics. Nature cell biology 20, 766-774, doi:10.1038/s41556-018-0131-2 (2018).
11 Sanford-Crane, H., Abrego, J. & Sherman, M. H. Fibroblasts as Modulators of Local and Systemic Cancer Metabolism. Cancers (Basel) 11, doi:10.3390/cancers11050619 (2019).
12 Schworer, S., Vardhana, S. A. & Thompson, C. B. Cancer Metabolism Drives a Stromal Regenerative Response. Cell Metab 29, 576-591, doi:10.1016/j.cmet.2019.01.015 (2019).
13 LeBleu, V. S. & Kalluri, R. A peek into cancer-associated fibroblasts: origins, functions and translational impact. Dis Model Mech 11, doi:10.1242/dmm.029447 (2018).
14 Luga, V. et al. Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell 151, 1542-1556, doi:10.1016/j.cell.2012.11.024 (2012).
15 Orimo, A. et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121, 335-348, doi:10.1016/j.cell.2005.02.034 (2005).
16 Bhowmick, N. A., Neilson, E. G. & Moses, H. L. Stromal fibroblasts in cancer initiation and progression. Nature 432, 332-337, doi:10.1038/nature03096 (2004).
17 Santos, A. M., Jung, J., Aziz, N., Kissil, J. L. & Pure, E. Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice. The Journal of clinical investigation 119, 3613-3625, doi:10.1172/JCI38988 (2009).
18 Davidson, S. et al. Single-Cell RNA Sequencing Reveals a Dynamic Stromal Niche That Supports Tumor Growth. Cell Rep 31, 107628, doi:10.1016/j.celrep.2020.107628 (2020).
19 Elyada, E. et al. Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts. Cancer Discov 9, 1102-1123, doi:10.1158/2159-8290.CD-19-0094 (2019).
20 Ohlund, D. et al. Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. J Exp Med 214, 579-596, doi:10.1084/jem.20162024 (2017).
21 Bartoschek, M. et al. Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing. Nature communications 9, 5150, doi:10.1038/s41467-018-07582-3 (2018).
22 De Palma, M., Biziato, D. & Petrova, T. V. Microenvironmental regulation of tumour angiogenesis. Nat Rev Cancer 17, 457-474, doi:10.1038/nrc.2017.51 (2017).
23 Sewell-Loftin, M. K. et al. Cancer-associated fibroblasts support vascular growth through mechanical force. Sci Rep 7, 12574, doi:10.1038/s41598-017-13006-x (2017).
24 Geller, A. C. et al. Melanoma epidemic: an analysis of six decades of data from the Connecticut Tumor Registry. J Clin Oncol 31, 4172-4178, doi:10.1200/JCO.2012.47.3728 (2013).
25 Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2018. CA Cancer J Clin 68, 7-30, doi:10.3322/caac.21442 (2018).
26 Pakos-Zebrucka, K. et al. The integrated stress response. EMBO Rep 17, 1374-1395, doi:10.15252/embr.201642195 (2016).
27 Costa-Mattioli, M. & Walter, P. The integrated stress response: From mechanism to disease. Science 368, doi:10.1126/science.aat5314 (2020).
28 Tameire, F., Verginadis, II & Koumenis, C. Cell intrinsic and extrinsic activators of the unfolded protein response in cancer: Mechanisms and targets for therapy. Semin Cancer Biol, doi:10.1016/j.semcancer.2015.04.002 (2015).
29 Harding, H. P. et al. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol Cell 11, 619-633, doi:10.1016/s1097-2765(03)00105-9 (2003).
30 Hart, L. S. et al. ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growthdey. The Journal of clinical investigation 122, 4621-4634, doi:10.1172/JCI62973 62973 [pii] (2012).
31 Dey, S. et al. ATF4-dependent induction of heme oxygenase 1 prevents anoikis and promotes metastasis. The Journal of clinical investigation 125, 2592-2608, doi:10.1172/jci78031 (2015).
32 Nguyen, H. G. et al. Development of a stress response therapy targeting aggressive prostate cancer. Sci Transl Med 10, doi:10.1126/scitranslmed.aar2036 (2018).
33 Tameire, F. et al. ATF4 couples MYC-dependent translational activity to bioenergetic demands during tumour progression. Nature cell biology 21, 889-899, doi:10.1038/s41556-019-0347-9 (2019).
34 Li, J. et al. Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy. Immunity 49, 178-193.e177, doi:10.1016/j.immuni.2018.06.006 (2018).
35 Tirosh, I. et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352, 189-196, doi:10.1126/science.aad0501 (2016).
36 Guerrero-Juarez, C. F. et al. Single-cell analysis reveals fibroblast heterogeneity and myeloid-derived adipocyte progenitors in murine skin wounds. Nature communications 10, 650, doi:10.1038/s41467-018-08247-x (2019).
37 Gelse, K., Poschl, E. & Aigner, T. Collagens--structure, function, and biosynthesis. Advanced drug delivery reviews 55, 1531-1546, doi:10.1016/j.addr.2003.08.002 (2003).
38 Han, J. et al. ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death. Nature cell biology 15, 481-490, doi:10.1038/ncb2738 (2013).
39 Shimoda, M., Mellody, K. T. & Orimo, A. Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression. Semin Cell Dev Biol 21, 19-25, doi:10.1016/j.semcdb.2009.10.002 (2010).
40 Gonzalez-Gonzalez, A. et al. Activating Transcription Factor 4 Modulates TGFbeta-Induced Aggressiveness in Triple-Negative Breast Cancer via SMAD2/3/4 and mTORC2 Signaling. Clin Cancer Res 24, 5697-5709, doi:10.1158/1078-0432.CCR-17-3125 (2018).
41 Chen, X. & Song, E. Turning foes to friends: targeting cancer-associated fibroblasts. Nat Rev Drug Discov 18, 99-115, doi:10.1038/s41573-018-0004-1 (2019).
42 Zhang, X. H. et al. Selection of bone metastasis seeds by mesenchymal signals in the primary tumor stroma. Cell 154, 1060-1073, doi:10.1016/j.cell.2013.07.036 (2013).
43 Gui, J. et al. Activation of p38α stress-activated protein kinase drives the formation of the pre-metastatic niche in the lungs. Nat Cancer in press (2020).
44 Overwijk, W. W. & Restifo, N. P. B16 as a mouse model for human melanoma. Curr Protoc Immunol Chapter 20, Unit 20 21, doi:10.1002/0471142735.im2001s39 (2001).
45 Ohlund, D., Elyada, E. & Tuveson, D. Fibroblast heterogeneity in the cancer wound. J Exp Med 211, 1503-1523, doi:10.1084/jem.20140692 (2014).
46 Pereira, B. A. et al. CAF Subpopulations: A New Reservoir of Stromal Targets in Pancreatic Cancer. Trends Cancer 5, 724-741, doi:10.1016/j.trecan.2019.09.010 (2019).
47 Gerstein, M. B. et al. Architecture of the human regulatory network derived from ENCODE data. Nature 489, 91-100, doi:10.1038/nature11245 (2012).
48 Wang, J. et al. Sequence features and chromatin structure around the genomic regions bound by 119 human transcription factors. Genome Res 22, 1798-1812, doi:10.1101/gr.139105.112 (2012).
49 Puram, S. V. et al. Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer. Cell 171, 1611-1624 e1624, doi:10.1016/j.cell.2017.10.044 (2017).
50 Lambrechts, D. et al. Phenotype molding of stromal cells in the lung tumor microenvironment. Nat Med 24, 1277-1289, doi:10.1038/s41591-018-0096-5 (2018).
51 Fukumura, D. et al. Tumor induction of VEGF promoter activity in stromal cells. Cell 94, 715-725, doi:10.1016/s0092-8674(00)81731-6 (1998).
52 Anderberg, C. et al. Paracrine signaling by platelet-derived growth factor-CC promotes tumor growth by recruitment of cancer-associated fibroblasts. Cancer research 69, 369-378, doi:10.1158/0008-5472.CAN-08-2724 (2009).
53 Compagni, A., Wilgenbus, P., Impagnatiello, M. A., Cotten, M. & Christofori, G. Fibroblast growth factors are required for efficient tumor angiogenesis. Cancer research 60, 7163-7169 (2000).
54 Kojima, Y. et al. Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts. Proceedings of the National Academy of Sciences of the United States of America 107, 20009-20014, doi:10.1073/pnas.1013805107 (2010).
55 Soufi, A., Donahue, G. & Zaret, K. S. Facilitators and impediments of the pluripotency reprogramming factors' initial engagement with the genome. Cell 151, 994-1004, doi:10.1016/j.cell.2012.09.045 (2012).
56 Beacham, D. A., Amatangelo, M. D. & Cukierman, E. Preparation of extracellular matrices produced by cultured and primary fibroblasts. Curr Protoc Cell Biol Chapter 10, Unit 10 19, doi:10.1002/0471143030.cb1009s33 (2007).
57 Beckonert, O. et al. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc 2, 2692-2703, doi:10.1038/nprot.2007.376 (2007).
58 Weljie, A. M., Newton, J., Mercier, P., Carlson, E. & Slupsky, C. M. Targeted profiling: quantitative analysis of 1H NMR metabolomics data. Anal Chem 78, 4430-4442, doi:10.1021/ac060209g (2006).
59 Cancer Genome Atlas Research, N. et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet 45, 1113-1120, doi:10.1038/ng.2764 (2013).
60 Nguyen, Nga Thi T. et al. RSAT 2018: regulatory sequence analysis tools 20th anniversary. Nucleic Acids Research 46, W209-W214, doi:10.1093/nar/gky317 (2018).
61 Anaya, J. OncoLnc: linking TCGA survival data to mRNAs, miRNAs, and lncRNAs. Peerj Comput Sci, doi:ARTN e67 10.7717/peerj-cs.67 (2016).